Inadequate antibody response to HBAg or suppressor T-cell defect in development of active chronic hepatitis.
D000284:Administration, Oral; D001439:Bacteroides / Q000187:drug effects / Q000302:isolation & purification; D001442:Bacteroides Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D002353:Carrier State; D005260:Female; D005500:Follow-Up Studies; D005831:Genital Diseases, Female / Q000601:surgery*; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects; D008795:Metronidazole / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011182:Postoperative Care; D011183:Postoperative Complications / Q000517:prevention & control*; D011300:Preoperative Care; D014621:Vagina / Q000601:surgery; D014626:Vaginal Smears
D008795:Metronidazole